Different β-cell secretory phenotype in non-obese compared to obese early type 2 diabetes

por Gudipaty, Lalitha, Rosenfeld, Nora K., Fuller, Carissa S., Cuchel, Marina, Rickels, Michael R.
Publicado en Diabetes Metab Res Rev (2020)

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes

por Gudipaty, Lalitha, Rosenfeld, Nora K., Fuller, Carissa S., Gallop, Robert, Schutta, Mark H., Rickels, Michael R.
Publicado 2014

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

por Sheikh, Saba, Gudipaty, Lalitha, De Leon, Diva D., Hadjiliadis, Denis, Kubrak, Christina, Rosenfeld, Nora K., Nyirjesy, Sarah C., Peleckis, Amy J., Malik, Saloni, Stefanovski, Darko, Cuchel, Marina, Rubenstein, Ronald C., Kelly, Andrea, Rickels, Michael R.
Publicado en Diabetes (2017)